How to cite item

Stereotactic ablative radiotherapy for operable stage I non-small cell lung cancer: not ready for prime time

   
@article{ATM28511,
	author = {James G. Connolly and Gregory D. Jones and Raul Caso and David R. Jones},
	title = {Stereotactic ablative radiotherapy for operable stage I non-small cell lung cancer: not ready for prime time},
	journal = {Annals of Translational Medicine},
	volume = {7},
	number = {Suppl 6},
	year = {2019},
	keywords = {},
	abstract = {Stereotactic ablative radiotherapy (SABR) is a wellaccepted treatment modality for patients with early-stage non-small cell lung cancer (NSCLC) who are thought to be inoperable or who decide not to undergo surgery (1). Some groups have recently suggested that SABR is a noninferior treatment approach for patients with operable stage I NSCLC (2,3). Surprisingly, there are no available data demonstrating the effectiveness of SABR at achieving pathologic complete response (pCR) in patients with NSCLC, a highly relevant point for all patients and perhaps particularly so for those who are candidates for surgery.},
	issn = {2305-5847},	url = {https://atm.amegroups.org/article/view/28511}
}